Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-MK-6240 PET Imaging of Tau in Alzheimer's Disease
NCT03373604Phase 2Completed
- Start
- Dec 2017
- Primary completion
- May 2022
- Countries
- 1
01
Overview
A Phase 2 trial of florquinitau in Alzheimer's disease (AD). Started Dec 2017; status: completed.
02
Drugs
florquinitau
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT03373604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03373604.